BENDER ROBERT & ASSOCIATES - Q1 2021 holdings

$311 Million is the total value of BENDER ROBERT & ASSOCIATES's 56 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was - .

 Value Shares↓ Weighting
VRTX NewVERTEX PHARMACEUTICALS INC$6,478,00030,145
+100.0%
2.08%
URGN NewUROGEN PHARMA LTD$606,00031,131
+100.0%
0.20%
CLVS NewCLOVIS ONCOLOGY INC$351,00050,000
+100.0%
0.11%
EOLS NewEVOLUS INC$325,00025,000
+100.0%
0.10%
IDXX NewIDEXX LABS INC$250,000510
+100.0%
0.08%
HON NewHONEYWELL INTL INC$217,0001,000
+100.0%
0.07%
PLSE NewPULSE BIOSCIENCES INC$209,0008,825
+100.0%
0.07%
JNCE NewJOUNCE THERAPEUTICS INC$103,00010,000
+100.0%
0.03%
CMRX NewCHIMERIX INC$96,00010,000
+100.0%
0.03%
SMMT NewSUMMIT THERAPEUTICS INC$83,00014,059
+100.0%
0.03%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-04-28
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
APPLE INC42Q3 202325.0%
INTUITIVE SURGICAL INC42Q3 20239.6%
ILLUMINA INC COM42Q3 20238.9%
AMAZON COM INC COM42Q3 20238.7%
LULULEMON ATHLETICA INC42Q3 20237.8%
MERCADOLIBRE INC COM42Q3 20237.8%
GILEAD SCIENCES INC C42Q3 20238.1%
ULTA SALON COSMETCS & FRAG I42Q3 20235.6%
STARBUCKS CORP COM42Q3 20233.1%
BRISTOL-MYERS SQUIBB CO42Q3 202315.1%

View BENDER ROBERT & ASSOCIATES's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-23
13F-HR2024-01-31
13F-HR2023-10-16
13F-HR2023-07-14
13F-HR2023-04-21
13F-HR2023-02-02
13F-HR2022-10-27
13F-HR2022-07-19
13F-HR2022-04-14
13F-HR2022-02-07

View BENDER ROBERT & ASSOCIATES's complete filings history.

Compare quarters

Export BENDER ROBERT & ASSOCIATES's holdings